{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:42:16Z","timestamp":1770903736653,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T00:00:00Z","timestamp":1473033600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s11940-016-0428-z","type":"journal-article","created":{"date-parts":[[2016,9,5]],"date-time":"2016-09-05T04:36:44Z","timestamp":1473050204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Current Treatment Options for Early-Onset Pediatric Epileptic Encephalopathies"],"prefix":"10.1007","volume":"18","author":[{"given":"Rolla","family":"Shbarou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,5]]},"reference":[{"issue":"6","key":"428_CR1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1528-1157.2001.10401.x","volume":"42","author":"J Engel Jr","year":"2001","unstructured":"Engel Jr J, E. International League Against. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. 2001;42(6):796\u2013803.","journal-title":"Epilepsia"},{"issue":"3","key":"428_CR2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3171\/2012.6.PEDS11424","volume":"10","author":"WP Rodgers","year":"2012","unstructured":"Rodgers WP et al. Interrater reliability of Engel, International League Against Epilepsy, and McHugh seizure outcome classifications following vagus nerve stimulator implantation. J Neurosurg Pediatr. 2012;10(3):226\u20139.","journal-title":"J Neurosurg Pediatr"},{"issue":"6","key":"428_CR3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00004691-200311000-00003","volume":"20","author":"S Ohtahara","year":"2003","unstructured":"Ohtahara S, Yamatogi Y. Epileptic encephalopathies in early infancy with suppression-burst. J Clin Neurophysiol. 2003;20(6):398\u2013407.","journal-title":"J Clin Neurophysiol"},{"issue":"6","key":"428_CR4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.braindev.2011.09.004","volume":"34","author":"P Pavone","year":"2012","unstructured":"Pavone P et al. Ohtahara syndrome with emphasis on recent genetic discovery. Brain Dev. 2012;34(6):459\u201368.","journal-title":"Brain Dev"},{"issue":"4","key":"428_CR5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/0883073810383018","volume":"26","author":"P Singhi","year":"2011","unstructured":"Singhi P, Ray M. Ohtahara syndrome with biotinidase deficiency. J Child Neurol. 2011;26(4):507\u20139.","journal-title":"J Child Neurol"},{"issue":"13","key":"428_CR6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.0b013e3181f4d7bf","volume":"75","author":"L Deprez","year":"2010","unstructured":"Deprez L et al. Clinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations. Neurology. 2010;75(13):1159\u201365.","journal-title":"Neurology"},{"issue":"7","key":"428_CR7","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/epi.12200","volume":"54","author":"M Kato","year":"2013","unstructured":"Kato M et al. Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation. Epilepsia. 2013;54(7):1282\u20137. This article highlights an important genetic mutation and its spectrum as a cause of Ohtahara syndrome.","journal-title":"Epilepsia"},{"issue":"12","key":"428_CR8","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1111\/j.1528-1167.2010.02728.x","volume":"51","author":"H Saitsu","year":"2010","unstructured":"Saitsu H et al. STXBP1 mutations in early infantile epileptic encephalopathy with suppression-burst pattern. Epilepsia. 2010;51(12):2397\u2013405.","journal-title":"Epilepsia"},{"issue":"11","key":"428_CR9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/WNL.0b013e3182a43e57","volume":"81","author":"K Nakamura","year":"2013","unstructured":"Nakamura K et al. Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome. Neurology. 2013;81(11):992\u20138.","journal-title":"Neurology"},{"key":"428_CR10","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/epi.13344","volume":"57","author":"H Kodera","year":"2016","unstructured":"Kodera H et al. De novo GABRA1 mutations in Ohtahara and West syndromes. Epilepsia. 2016;57:566\u201373.","journal-title":"Epilepsia"},{"issue":"8","key":"428_CR11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/epi.13057","volume":"56","author":"JM Wilmshurst","year":"2015","unstructured":"Wilmshurst JM et al. Summary of recommendations for the management of infantile seizures: Task Force Report for the ILAE Commission of Pediatrics. Epilepsia. 2015;56(8):1185\u201397. This article summarizes the major up-to-date recommendations for treatment of early-onset epileptic encephalopathies.","journal-title":"Epilepsia"},{"issue":"2","key":"428_CR12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pediatrneurol.2013.10.006","volume":"50","author":"WW Tso","year":"2014","unstructured":"Tso WW et al. Folinic acid responsive epilepsy in Ohtahara syndrome caused by STXBP1 mutation. Pediatr Neurol. 2014;50(2):177\u201380.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"428_CR13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejpn.2011.07.015","volume":"16","author":"M Mastrangelo","year":"2012","unstructured":"Mastrangelo M, Celato A, Leuzzi V. A diagnostic algorithm for the evaluation of early onset genetic-metabolic epileptic encephalopathies. Eur J Paediatr Neurol. 2012;16(2):179\u201391.","journal-title":"Eur J Paediatr Neurol"},{"issue":"6","key":"428_CR14","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.ejpn.2014.06.007","volume":"18","author":"R Cohen","year":"2014","unstructured":"Cohen R et al. Two siblings with early infantile myoclonic encephalopathy due to mutation in the gene encoding mitochondrial glutamate\/H+ symporter SLC25A22. Eur J Paediatr Neurol. 2014;18(6):801\u20135.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"428_CR15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s40263-013-0041-6","volume":"27","author":"A McTague","year":"2013","unstructured":"McTague A, Cross JH. Treatment of epileptic encephalopathies. CNS Drugs. 2013;27(3):175\u201384. This article presents a variety of different treatments for epileptic encephalopathies and a clinical summary for each type of genetic epilepsy.","journal-title":"CNS Drugs"},{"issue":"10","key":"428_CR16","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1528-1157.1995.tb00961.x","volume":"36","author":"G Coppola","year":"1995","unstructured":"Coppola G et al. Migrating partial seizures in infancy: a malignant disorder with developmental arrest. Epilepsia. 1995;36(10):1017\u201324.","journal-title":"Epilepsia"},{"issue":"6","key":"428_CR17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00004691-200311000-00002","volume":"20","author":"R Nabbout","year":"2003","unstructured":"Nabbout R, Dulac O. Epileptic encephalopathies: a brief overview. J Clin Neurophysiol. 2003;20(6):393\u20137.","journal-title":"J Clin Neurophysiol"},{"key":"428_CR18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/B978-0-444-52891-9.00062-2","volume":"111","author":"G Coppola","year":"2013","unstructured":"Coppola G. Malignant migrating partial seizures in infancy. Handb Clin Neurol. 2013;111:605\u20139.","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"428_CR19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/ng.2441","volume":"44","author":"G Barcia","year":"2012","unstructured":"Barcia G et al. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. Nat Genet. 2012;44(11):1255\u20139.","journal-title":"Nat Genet"},{"issue":"6","key":"428_CR20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.23998","volume":"74","author":"A Poduri","year":"2013","unstructured":"Poduri A et al. SLC25A22 is a novel gene for migrating partial seizures in infancy. Ann Neurol. 2013;74(6):873\u201382.","journal-title":"Ann Neurol"},{"issue":"9","key":"428_CR21","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1111\/epi.13072","volume":"56","author":"C Ohba","year":"2015","unstructured":"Ohba C et al. De novo KCNT1 mutations in early-onset epileptic encephalopathy. Epilepsia. 2015;56(9):e121\u20138.","journal-title":"Epilepsia"},{"issue":"10","key":"428_CR22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.seizure.2014.06.016","volume":"23","author":"R Caraballo","year":"2014","unstructured":"Caraballo R et al. Epilepsy of infancy with migrating focal seizures: six patients treated with bromide. Seizure. 2014;23(10):899\u2013902.","journal-title":"Seizure"},{"issue":"2","key":"428_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1684\/j.1950-6945.1999.tb00309.x","volume":"1","author":"F Gerard","year":"1999","unstructured":"Gerard F et al. Focal seizures versus focal epilepsy in infancy: a challenging distinction. Epileptic Disord. 1999;1(2):135\u20139.","journal-title":"Epileptic Disord"},{"issue":"11","key":"428_CR24","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1528-1157.1999.tb02048.x","volume":"40","author":"J Perez","year":"1999","unstructured":"Perez J et al. Stiripentol: efficacy and tolerability in children with epilepsy. Epilepsia. 1999;40(11):1618\u201326.","journal-title":"Epilepsia"},{"issue":"1","key":"428_CR25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.eplepsyres.2009.05.004","volume":"86","author":"MR Cilio","year":"2009","unstructured":"Cilio MR et al. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy. Epilepsy Res. 2009;86(1):66\u201371.","journal-title":"Epilepsy Res"},{"issue":"1","key":"428_CR26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1684\/epd.2011.0406","volume":"13","author":"M Vendrame","year":"2011","unstructured":"Vendrame M et al. Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases. Epileptic Disord. 2011;13(1):18\u201321.","journal-title":"Epileptic Disord"},{"issue":"4","key":"428_CR27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0929-693X(03)00030-7","volume":"10","author":"LL Francois","year":"2003","unstructured":"Francois LL et al. Ketogenic regime as anti-epileptic treatment: its use in 29 epileptic children. Arch Pediatr. 2003;10(4):300\u20136.","journal-title":"Arch Pediatr"},{"issue":"3","key":"428_CR28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10143-008-0134-8","volume":"31","author":"N Zamponi","year":"2008","unstructured":"Zamponi N et al. Vagus nerve stimulation (VNS) is effective in treating catastrophic 1 epilepsy in very young children. Neurosurg Rev. 2008;31(3):291\u20137.","journal-title":"Neurosurg Rev"},{"issue":"6","key":"428_CR29","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1528-1157.1999.tb00773.x","volume":"40","author":"E Trevathan","year":"1999","unstructured":"Trevathan E, Murphy CC, Yeargin-Allsopp M. The descriptive epidemiology of infantile spasms among Atlanta children. Epilepsia. 1999;40(6):748\u201351.","journal-title":"Epilepsia"},{"issue":"2","key":"428_CR30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/01.WNL.0000068012.69928.92","volume":"61","author":"M Kato","year":"2003","unstructured":"Kato M et al. Polyalanine expansion of ARX associated with cryptogenic West syndrome. Neurology. 2003;61(2):267\u201376.","journal-title":"Neurology"},{"issue":"4","key":"428_CR31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1399-0004.2009.01194.x","volume":"76","author":"C Nemos","year":"2009","unstructured":"Nemos C et al. Mutational spectrum of CDKL5 in early-onset encephalopathies: a study of a large collection of French patients and review of the literature. Clin Genet. 2009;76(4):357\u201371.","journal-title":"Clin Genet"},{"issue":"7466","key":"428_CR32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12439","volume":"501","author":"KC Epi","year":"2013","unstructured":"Epi KC et al. De novo mutations in epileptic encephalopathies. Nature. 2013;501(7466):217\u201321.","journal-title":"Nature"},{"issue":"1","key":"428_CR33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajhg.2008.06.001","volume":"83","author":"CR Marshall","year":"2008","unstructured":"Marshall CR et al. Infantile spasms is associated with deletion of the MAGI2 gene on chromosome 7q11.23-q21.11. Am J Hum Genet. 2008;83(1):106\u201311.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"428_CR34","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1111\/j.1528-1167.2010.02767.x","volume":"51","author":"M Otsuka","year":"2010","unstructured":"Otsuka M et al. STXBP1 mutations cause not only Ohtahara syndrome but also West syndrome\u2014result of Japanese cohort study. Epilepsia. 2010;51(12):2449\u201352.","journal-title":"Epilepsia"},{"issue":"6","key":"428_CR35","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1212\/01.WNL.0000086379.71183.78","volume":"61","author":"RH Wallace","year":"2003","unstructured":"Wallace RH et al. Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology. 2003;61(6):765\u20139.","journal-title":"Neurology"},{"issue":"13","key":"428_CR36","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1212\/WNL.0b013e3181b9cebc","volume":"73","author":"I Ogiwara","year":"2009","unstructured":"Ogiwara I et al. De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies. Neurology. 2009;73(13):1046\u201353.","journal-title":"Neurology"},{"issue":"Suppl 2","key":"428_CR37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1528-1167.2011.02994.x","volume":"52","author":"C Dravet","year":"2011","unstructured":"Dravet C. The core Dravet syndrome phenotype. Epilepsia. 2011;52 Suppl 2:3\u20139.","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"428_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1528-1167.2006.00688.x","volume":"47","author":"M Wolff","year":"2006","unstructured":"Wolff M, Casse-Perrot C, Dravet C. Severe myoclonic epilepsy of infants (Dravet syndrome): natural history and neuropsychological findings. Epilepsia. 2006;47 Suppl 2:45\u20138.","journal-title":"Epilepsia"},{"issue":"12","key":"428_CR39","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1212\/01.WNL.0000069463.41870.2F","volume":"60","author":"R Nabbout","year":"2003","unstructured":"Nabbout R et al. Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology. 2003;60(12):1961\u20137.","journal-title":"Neurology"},{"issue":"2","key":"428_CR40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1086\/338710","volume":"70","author":"LA Harkin","year":"2002","unstructured":"Harkin LA et al. Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet. 2002;70(2):530\u20136.","journal-title":"Am J Hum Genet"},{"issue":"34","key":"428_CR41","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1523\/JNEUROSCI.2475-09.2009","volume":"29","author":"GA Patino","year":"2009","unstructured":"Patino GA et al. A functional null mutation of SCN1B in a patient with Dravet syndrome. J Neurosci. 2009;29(34):10764\u201378.","journal-title":"J Neurosci"},{"issue":"3","key":"428_CR42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.nbd.2012.05.017","volume":"47","author":"C Lossin","year":"2012","unstructured":"Lossin C et al. Compromised function in the Na(v)1.2 Dravet syndrome mutation R1312T. Neurobiol Dis. 2012;47(3):378\u201384.","journal-title":"Neurobiol Dis"},{"issue":"8","key":"428_CR43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1212\/WNL.7.8.523","volume":"7","author":"WM Landau","year":"1957","unstructured":"Landau WM, Kleffner FR. Syndrome of acquired aphasia with convulsive disorder in children. Neurology. 1957;7(8):523\u201330.","journal-title":"Neurology"},{"issue":"1","key":"428_CR44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0387-7604(89)80008-7","volume":"11","author":"S Nakano","year":"1989","unstructured":"Nakano S, Okuno T, Mikawa H. Landau-Kleffner syndrome. EEG topographic studies. Brain Dev. 1989;11(1):43\u201350.","journal-title":"Brain Dev"},{"issue":"9","key":"428_CR45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ng.2726","volume":"45","author":"G Lesca","year":"2013","unstructured":"Lesca G et al. GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction. Nat Genet. 2013;45(9):1061\u20136.","journal-title":"Nat Genet"},{"issue":"2","key":"428_CR46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.seizure.2013.09.016","volume":"23","author":"RH Caraballo","year":"2014","unstructured":"Caraballo RH et al. Landau-Kleffner syndrome: a study of 29 patients. Seizure. 2014;23(2):98\u2013104. This article provides a nice summary of the electroclinical features, etiology, treatment, and prognosis of 29 patients with Landau\u2013Kleffner syndrome (LKS) with a long-term follow-up.","journal-title":"Seizure"},{"issue":"2","key":"428_CR47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1469-5812.2005.00134.x-i1","volume":"1","author":"PL Pearl","year":"2001","unstructured":"Pearl PL, Carrazana EJ, Holmes GL. The Landau-Kleffner syndrome. Epilepsy Curr. 2001;1(2):39\u201345.","journal-title":"Epilepsy Curr"},{"issue":"9","key":"428_CR48","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1017\/S0012162206001630","volume":"48","author":"S Gallagher","year":"2006","unstructured":"Gallagher S et al. Efficacy of very high dose steroid treatment in a case of Landau-Kleffner syndrome. Dev Med Child Neurol. 2006;48(9):766\u20139.","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"428_CR49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0887-8994(01)00402-7","volume":"26","author":"MA Mikati","year":"2002","unstructured":"Mikati MA et al. Efficacy of intravenous immunoglobulin in Landau-Kleffner syndrome. Pediatr Neurol. 2002;26(4):298\u2013300.","journal-title":"Pediatr Neurol"},{"issue":"Pt 6","key":"428_CR50","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/brain\/118.6.1529","volume":"118","author":"F Morrell","year":"1995","unstructured":"Morrell F et al. Landau-Kleffner syndrome. Treatment with subpial intracortical transection. Brain. 1995;118(Pt 6):1529\u201346.","journal-title":"Brain"},{"key":"428_CR51","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/dmcn.12976","volume":"58","author":"A Papandreou","year":"2016","unstructured":"Papandreou A et al. GABRB3 mutations: a new and emerging cause of early infantile epileptic encephalopathy. Dev Med Child Neurol. 2016;58:416\u201320.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"428_CR52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.pediatrneurol.2012.05.001","volume":"47","author":"AF VanStraten","year":"2012","unstructured":"VanStraten AF, Ng YT. Update on the management of Lennox-Gastaut syndrome. Pediatr Neurol. 2012;47(3):153\u201361.","journal-title":"Pediatr Neurol"},{"issue":"5","key":"428_CR53","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1469-8749.2012.04233.x","volume":"54","author":"ME Lemmon","year":"2012","unstructured":"Lemmon ME et al. Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution\u2019s experience and summary of the literature. Dev Med Child Neurol. 2012;54(5):464\u20138.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"428_CR54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1212\/01.wnl.0000316306.08751.28","volume":"71","author":"M Coutelier","year":"2008","unstructured":"Coutelier M et al. Neuroserpin mutation causes electrical status epilepticus of slow-wave sleep. Neurology. 2008;71(1):64\u20136.","journal-title":"Neurology"},{"issue":"9","key":"428_CR55","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1528-1167.2012.03559.x","volume":"53","author":"G Lesca","year":"2012","unstructured":"Lesca G et al. Epileptic encephalopathies of the Landau-Kleffner and continuous spike and waves during slow-wave sleep types: genomic dissection makes the link with autism. Epilepsia. 2012;53(9):1526\u201338.","journal-title":"Epilepsia"},{"issue":"4","key":"428_CR56","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.eplepsyres.2014.02.009","volume":"108","author":"G Zanni","year":"2014","unstructured":"Zanni G et al. A novel mutation in the endosomal Na+\/H+ exchanger NHE6 (SLC9A6) causes Christianson syndrome with electrical status epilepticus during slow-wave sleep (ESES). Epilepsy Res. 2014;108(4):811\u20135.","journal-title":"Epilepsy Res"},{"issue":"4","key":"428_CR57","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ajhg.2008.01.013","volume":"82","author":"GD Gilfillan","year":"2008","unstructured":"Gilfillan GD et al. SLC9A6 mutations cause X-linked mental retardation, microcephaly, epilepsy, and ataxia, a phenotype mimicking Angelman syndrome. Am J Hum Genet. 2008;82(4):1003\u201310.","journal-title":"Am J Hum Genet"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-016-0428-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-016-0428-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-016-0428-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T06:01:08Z","timestamp":1718776868000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-016-0428-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,5]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["428"],"URL":"https:\/\/doi.org\/10.1007\/s11940-016-0428-z","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,5]]},"article-number":"44"}}